Explore the groundbreaking session titled "Bio-Intelligence: Generative Molecules to Autonomous Care" from SuperAI Singapore 2025, where pioneers in AI-driven healthcare discuss the transformative potential of generative artificial intelligence. Moderated by Alita Masab from DCVC, this panel dives into the practical deployment of AI in healthcare, biotech, pharma, and diagnostics.

​

Join Alita as she presents a distinguished panel featuring Munjaw Shah of Hypocratic AI, Alex Zhavoronkov of Insilico Medicine, and Mahiar Saghai of Deep Cell. Discover how generative AI is revolutionizing healthcare delivery, drug discovery, and diagnostics. Munjaw Shah discusses how Hypocratic AI is utilizing generative AI agents to deliver nursing care, reducing costs and alleviating workforce shortages. Alex Zhavoronkov shares how Insilico Medicine's cutting-edge AI platform accelerates drug discovery, reducing timeframes from years to months and drastically lowering costs, showcasing real-world applications with clinical trial successes. Meanwhile, Mahiar Saghai reveals how Deep Cell's AI-powered product is transforming cellular diagnostics and drug impact analysis.

​

The panelists also navigate the complex landscape of AI regulation, highlighting the support and challenges from regulatory bodies like the FDA and European Union. Delve into insightful discussions on the promising applications of AI, the hurdles of creating an AI doctor, and the critical innovations necessary to meet regulatory standards. With an engaging exploration of models, data, and distribution in AI's future, this session is a must-watch for anyone fascinated by AI's impact on healthcare and biotechnology.

​

Do not miss the opportunity to engage with this critical discourse on the future of AI in healthcare. Like, comment, and subscribe for more insightful content from SuperAI Singapore 2025.